Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02544633
Title Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Mirati Therapeutics Inc.
Age Groups: adult
Covered Countries USA | ITA | GBR | CAN | AUS

Additional content available in CKB BOOST